Supplemental Figure S2 from [&lt;sup&gt;18&lt;/sup&gt;F]FluorThanatrace ([&lt;sup&gt;18&lt;/sup&gt;F]FTT) PET Imaging of PARP-Inhibitor Drug-Target Engagement as a Biomarker of Response in Ovarian Cancer, a Pilot Study